Astera Labs, Inc. (ALAB) FY2025 Q1 Balance Sheet

Astera Labs, Inc. (ALAB) FY2025 Q1 Balance Sheet

Balance sheet as of 2025-03-31. The chart shows assets, liabilities and equity at that date.

Assets

1,121,694,000 US dollars

Current assets

1,075,819,000 US dollars

Non-current assets

45,875,000 US dollars

Liabilities

80,132,000 US dollars

Current liabilities

77,280,000 US dollars

Non-current liabilities

2,852,000 US dollars

Equity

1,041,562,000 US dollars

Marketable securities

838,295,000 US dollars

Cash and cash equivalents

86,431,000 US dollars

Accounts receivable, net

69,778,000 US dollars

Inventory

51,057,000 US dollars

Prepaid expenses and other current assets

30,258,000 US dollars

Property and equipment, net

39,474,000 US dollars

Other assets

6,401,000 US dollars

Accrued expenses and other current liabilities

47,767,000 US dollars

Accounts payable

29,513,000 US dollars

Other liabilities

2,852,000 US dollars

Additional paid-in capital

1,216,495,000 US dollars

Accumulated other comprehensive income

2,028,000 US dollars

Common stock, $0.0001 par value; 1,000,000 shares authorized as of March 31, 2025 and December 31, 2024; 164,907 and 162,018 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively

16,000 US dollars

Accumulated deficit

negative 176,977,000 US dollars

Gross equity (calculated)

1,218,539,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

• Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
• Treasury shares and other negative equity contributions reduce equity.